Quantcast

Latest Mitral valve Stories

2014-09-17 08:29:17

Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc. today announced that new long-term outcomes data from the TITAN II clinical trial of its enhanced CARILLON Mitral Contour System showed significant and sustained improvements in mitral regurgitation, functional improvement, quality of life and reverse cardiac remodeling. The long-term safety and efficacy data,...

2014-09-15 12:27:22

Tiara(TM) Transcatheter Mitral Valve program featured in multiple scientific presentations NASDAQ: NVCNTSX: NVC WASHINGTON, DC, Sept. 15, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) announced today that its Reducer(TM) technology was featured in a "live case" broadcast on Sunday, September 14, 2014 at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. A Clinical update on the company's Tiara(TM)...

2014-09-10 08:29:45

Harpoon Medical Has Received More than $3M of its Series A Financing to Fund the Initial Clinical Evaluation of the Company's Minimally Invasive Mitral Valve Repair Device STEVENSVILLE, Md., Sept. 10, 2014 /PRNewswire/ -- Harpoon Medical, Inc., a medical device company focused on the development and commercialization of a minimally invasive, beating heart mitral valve repair technology, announced today that the company has successfully raised $3.2M of new capital and expects to...

2014-09-09 12:29:07

STASIS Clinical Study Begins in Europe NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ -- Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology simplifies minimally invasive aortic valve replacement procedures. The patient is the first to be enrolled in the Secure Transapical Access and Closure Study (STASIS) being conducted in Europe. The first STASIS case was performed by Dr....

2014-08-12 12:27:43

- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug. 12, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) recently issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to Transcatheter Mitral Valve Repair with Abbott's (NYSE: ABT) MitraClip(® )System. The MitraClip System is a...

2014-08-07 23:11:05

HeartStitch, Inc. receives landmark patent "Suturing Devices and Methods for Suturing an Anatomic Valve" FOUNTAIN VALLEY, CA – (PRWEB) August 07, 2014 -- By: HeartStitch Prof. Anthony Nobles, CEO of HeartStitch HeartStitch, Inc. today announced that it has received another US Patent for its HeartStitch Technology. The patent “Suturing devices and methods for suturing an anatomic valve” is for the HeartStitch MR and AP products that are designed to allow physicians to be...

2014-08-07 16:27:55

Valve Clinic Team is first locally to use device for Mitral Valve Regurgitation CLEARWATER, Fla., Aug. 7, 2014 /PRNewswire-USNewswire/ -- Morton Plant Hospital continues to offer the latest treatments in cardiac care, particularly for individuals with heart valve problems who may not be able to have traditional open heart surgery. Morton Plant is among the first hospitals in Florida and the first locally to use the new MitraClip device for people with severe mitral valve regurgitation....

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...

2014-07-14 23:02:06

Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com. According to the report, Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020. London, UK (PRWEB) July 14, 2014 Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020, with the transcatheter heart valve devices sector (composed of the transcatheter heart...

2014-07-07 23:07:45

HeartStitch TA Receives Strong Reviews from Physcians at Congenital & Structural Interventions Congress (CSI) in Frankfurt Fountain Valley, CA (PRWEB) July 07, 2014 HeartStitch, Inc. today announced that Prof. Anthony Nobles, CEO of HeartStitch, presented final results of 148 Porcine Transapical Closures treated with HeartStitch TA Access & Closure System. HeartStitch received positive reviews from cardiologists and cardiac surgeons including members of the panel as well as...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related